Nawal M Alrasheed
Overview
Explore the profile of Nawal M Alrasheed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alobaid S, Alshahrani R, Alonazi A, Alrasheed N, Alamin M, Alshammari T, et al.
Pharmaceuticals (Basel)
. 2024 Mar;
17(3).
PMID: 38543160
One of the possible candidates for the treatment of diabetic cardiomyopathy is liraglutide, a glucagon-like peptide-1 receptor (GLP1R) agonist. In this study, the impacts of liraglutide on the integrin-linked kinase...
2.
Bin Dayel A, Alonazi A, Alrasheed N, Alamin M, Sarawi W, Alharbi A, et al.
J Pharm Pharmacol
. 2023 Nov;
76(1):64-73.
PMID: 37992247
Objectives: Diabetic cardiomyopathy is a known complication of diabetes mellitus. Herein, we aimed to determine whether glycemic control mediated by sitagliptin, a dipeptidyl peptidase-4 inhibitor, can ameliorate diabetic myocardial abnormalities...
3.
Al-Qabbaa S, Qaboli S, Alshammari T, Alamin M, Alrajeh H, Almuthnabi L, et al.
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047505
Diabetic nephropathy (DN) is a microvascular complication of diabetes mellitus. This study examined the therapeutic effects of sitagliptin, a dipeptidyl peptidase inhibitor, on DN and explored the underlying mechanism. Male...
4.
Alrasheed N, Alammari R, Alshammari T, Alamin M, Alharbi A, Alonazi A, et al.
BMC Cardiovasc Disord
. 2023 Mar;
23(1):153.
PMID: 36964489
Background: Myocardial infarction (MI) is considered a public health problem. According to the World Health Organization, MI is a leading cause of death and comorbidities worldwide. Activation of the α1A...